Vimian Group AB (publ) (VIMGF)
USD 3.62
(0.0%)
USD 3.62
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 41.27 Million EUR | 8.03% |
| 2022 | 54.43 Million USD | 25.82% |
| 2021 | 43.26 Million USD | 107.42% |
| 2020 | 20.85 Million USD | 439.69% |
| 2019 | 3.86 Million USD | 537.09% |
| 2018 | 606.67 Thousand EUR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q3 | 10.09 Million USD | -23.7% |
| 2024 Q2 | 20.81 Million USD | -1.07% |
| 2024 Q1 | 13.36 Million EUR | 395.26% |
| 2023 FY | 58.8 Million USD | 8.03% |
| 2023 Q2 | 16.45 Million USD | -21.69% |
| 2023 Q1 | 21 Million USD | 70.61% |
| 2023 Q3 | 12.62 Million USD | -23.28% |
| 2023 Q4 | 4.5 Million USD | -64.3% |
| 2022 Q3 | 8.7 Million USD | -34.39% |
| 2022 FY | 54.43 Million USD | 25.82% |
| 2022 Q4 | 12.31 Million USD | 41.48% |
| 2022 Q2 | 13.26 Million EUR | -23.77% |
| 2022 Q1 | 17.4 Million EUR | 175.19% |
| 2021 FY | 43.26 Million USD | 107.42% |
| 2021 Q3 | 6.29 Million EUR | -38.19% |
| 2021 Q4 | 6.32 Million EUR | 0.51% |
| 2021 Q2 | 10.17 Million EUR | -25.11% |
| 2021 Q1 | 13.59 Million EUR | 2.02% |
| 2020 Q4 | 13.32 Million EUR | 313.28% |
| 2020 FY | 20.85 Million USD | 439.69% |
| 2020 Q2 | -1.57 Million EUR | -431.72% |
| 2020 Q1 | 476 Thousand EUR | 0.0% |
| 2020 Q3 | 3.22 Million EUR | 304.18% |
| 2019 FY | 3.86 Million USD | 537.09% |
| 2018 FY | 606.67 Thousand EUR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| American Bio Medica Corporation | -1.24 Million USD | 3422.947% |
| Arrayit Corporation | -3.62 Million USD | 1239.29% |
| Atlantic International Corp. | -5.73 Million USD | 819.947% |
| Biocept, Inc. | -31.98 Million USD | 229.04% |
| Bioqual, Inc. | -19.63 Thousand USD | 210258.876% |
| CardioGenics Holdings Inc | -772.14 Thousand USD | 5445.001% |
| DermTech, Inc. | -103.73 Million USD | 139.783% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 2.48 Billion USD | 98.34% |
| HTG Molecular Diagnostics, Inc. | -20.82 Million USD | 298.136% |
| iMD Companies, Inc. | -175.44 Thousand USD | 23623.477% |
| IDenta Corp. | -1499.00 USD | 2753335.49% |
| Interpace Biosciences, Inc. | 2.8 Million USD | -1371.862% |
| Integrative Health Technologies, Inc. | 38.69 Thousand USD | -106570.974% |
| InVitro International | -25.33 Thousand USD | 162975.409% |
| Lumos Diagnostics Holdings Limited | -7.12 Million USD | 679.486% |
| Many Bright Ideas Technologies Inc. | -58.11 Thousand USD | 71119.755% |
| Medical Imaging Corp. | -819.48 Thousand USD | 5136.242% |
| NovelStem International Corp. | -3.52 Million USD | 1270.543% |
| Optigenex Inc. | 1.39 Million USD | -2867.354% |
| PharmChem, Inc. | 973.14 Thousand USD | -4140.983% |
| Proteome Sciences plc | -1.62 Million USD | 2646.021% |
| Response Genetics, Inc | -21.37 Million USD | 293.063% |
| Rennova Health, Inc. | -1.4 Million USD | 3027.989% |
| RushNet, Inc. | -684.7 Thousand USD | 6127.559% |
| ScreenPro Security Inc. | -2.59 Million USD | 1691.982% |
| Stella Diagnostics Inc. | -11.42 Million USD | 461.172% |
| StageZero Life Sciences Ltd. | -7.74 Million USD | 632.752% |
| Todos Medical Ltd. | -9.74 Million USD | 523.379% |